QTRX Quanterix Corp
Laboratory Analytical Instruments · Nasdaq · SEC CIK 1503274 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY13.8%
TTM net income YoY-16.2%
TTM EPS YoY0.0%
Revenue 3-yr CAGR8.3%
Net income 3-yr CAGR—
Margins
Gross margin41.7%
Operating margin-93.2%
Net margin-75.0%
FCF margin-37.8%
EBITDA margin-76.7%
Returns
ROE-41.7%
ROA-29.9%
ROIC (approx.)-47.4%
Asset turnover0.40x
Leverage & solvency
Liabilities / assets27.0%
Debt / equity0.00x
Current ratio3.09x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.50x
Accruals ratio-14.9%
Payout ratio—
Capex / revenue0.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $34.97M | $32.91M | $36.41M | $43.85M | $40.23M | $24.48M | $30.33M | $35.16M |
| Cost of revenue | $21.47M | $20.23M | $20.85M | $23.82M | $24.33M | $14.47M | $15.49M | $12.99M |
| Gross profit | $13.50M | $12.67M | $15.57M | $20.04M | $15.90M | $10.00M | $14.84M | $22.17M |
| R&D expense | $7.37M | $7.82M | $7.32M | $8.80M | $8.01M | $9.08M | $10.04M | $8.07M |
| SG&A expense | $28.45M | $27.35M | $29.77M | $35.14M | $38.04M | $30.35M | $31.17M | $28.59M |
| Operating income | -$22.50M | -$49.43M | -$41.36M | -$24.75M | -$37.33M | -$37.10M | -$26.37M | -$14.77M |
| Pretax income | -$21.30M | -$48.99M | -$17.55M | -$22.77M | -$36.00M | -$30.09M | -$23.42M | -$11.64M |
| Income tax | $288,000 | -$54,000 | -$7,000 | $345,000 | -$2.48M | -$73,000 | -$2.91M | -$8,000 |
| Net income | -$21.59M | -$48.93M | -$17.54M | -$23.12M | -$33.52M | -$30.01M | -$20.50M | -$11.63M |
| EBITDA | -$16.06M | -$43.30M | -$35.76M | -$18.52M | -$31.89M | -$35.10M | -$24.18M | -$13.05M |
| EPS (basic) | -0.46 | -1.04 | -0.37 | — | -0.73 | -0.77 | -0.53 | — |
| EPS (diluted) | -0.46 | -1.04 | -0.37 | — | -0.73 | -0.77 | -0.53 | — |
| Weighted avg. shares (diluted) | 47.39M | 47.17M | 46.98M | — | 46.06M | 38.89M | 38.72M | — |
| Banking | ||||||||
| Net interest income | — | — | $892,000 | $1.16M | $1.45M | $2.69M | $3.27M | $3.49M |
| Provision for credit losses | $477,000 | $462,000 | $528,000 | $1.00M | $86,000 | $189,000 | $186,000 | -$32,000 |
| Balance sheet | ||||||||
| Cash & equivalents | $35.86M | $44.17M | $36.18M | $29.84M | $38.30M | $132.90M | $76.51M | $59.32M |
| Short-term investments | $41.49M | $49.36M | $63.08M | $88.39M | $96.51M | $128.28M | $190.37M | $232.41M |
| Receivables | $27.20M | $22.34M | $26.78M | $29.97M | $33.03M | $23.55M | $28.26M | $32.14M |
| Inventory | $44.82M | $47.60M | $50.96M | $54.76M | $54.96M | $30.14M | $31.03M | $32.77M |
| Current assets | $158.12M | $171.05M | $185.72M | $212.26M | $233.28M | $322.12M | $335.00M | $363.59M |
| PP&E, net | $18.29M | $20.00M | $21.37M | $23.67M | $25.77M | $15.75M | $16.46M | $17.15M |
| Goodwill | $0 | $0 | $26.71M | $26.38M | $23.46M | $0 | $6.57M | $0 |
| Intangibles | $102.41M | $105.78M | $109.16M | $131.79M | $135.15M | $16.33M | $16.52M | $4.03M |
| Total assets | $300.44M | $319.63M | $366.67M | $418.77M | $444.14M | $375.61M | $396.51M | $406.53M |
| Current liabilities | $51.13M | $50.37M | $49.91M | $74.76M | $77.35M | $48.20M | $40.40M | $42.01M |
| Total liabilities | $81.09M | $82.42M | $84.53M | $123.04M | $129.61M | $83.15M | $80.12M | $76.50M |
| Shareholders' equity | $219.35M | $237.21M | $282.14M | $295.73M | $314.53M | $292.46M | $316.39M | $330.04M |
| Shares outstanding | 47.45M | 47.13M | 47.06M | 46.74M | 46.68M | 38.87M | 38.80M | 38.57M |
| Cash flow statement | ||||||||
| Operating cash flow | -$16.20M | -$5.12M | -$18.11M | -$16.44M | -$41.25M | -$5.66M | -$13.89M | -$4.30M |
| Capital expenditure | $75,000 | $96,000 | $87,000 | -$98,000 | $677,000 | $777,000 | $1.26M | $412,000 |
| Free cash flow | -$16.28M | -$5.21M | -$18.19M | -$16.35M | -$41.93M | -$6.43M | -$15.14M | -$4.71M |
| Investing cash flow | $7.90M | $13.66M | $25.26M | $8.44M | -$52.85M | $61.88M | $32.76M | $32.38M |
| Financing cash flow | $52,000 | -$527,000 | -$770,000 | -$522,000 | $150,000 | -$429,000 | $93,000 | $41,000 |
| Depreciation & amortization | $6.43M | $6.13M | $5.60M | $6.23M | $5.43M | $2.00M | $2.19M | $1.72M |
| Stock-based compensation | $3.78M | $4.21M | $4.53M | $4.42M | $5.47M | $5.37M | $5.46M | $4.84M |
Free plan shows the latest 8 periods; Pro shows all 39 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.